Lakeshore Biopharma Co.LSBCF
13F holders, Q2 2025 (June 30)7holders −2
0new positions
2sold out
1famous investor
$1.02avg. 13F price*
At the end of Q2 2025, 7 institutions reported holding Lakeshore Biopharma Co. Ltd. (LSBCF) in their 13F filings, down 2 from Q1 2025. 0 opened new positions and 2 sold out. The largest holders were FMR LLC ($119K), HHLR Advisors, LTD. ($77K) and Orbimed Advisors LLC ($56K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lakeshore Biopharma Co. Ltd.
- CUSIP
- G9845F208
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $44K |
All 13F filers, Q1 2025 → Q2 2025: 9,846 shares bought and 1,134,229 shares sold, net −1,124,383 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| FMR LLC | 0.00% | No change | 116,508 | $119K |
| HHLR Advisors, LTD. | 0.00% | No change | 75,179 | $77K |
| Orbimed Advisors LLC | 0.00% | Reduce -61.0% | 54,799 | $56K |
| Superstring Capital Management LP | 0.04% | No change | 30,792 | $31K |
| Barclays PLC | 0.00% | No change | 24,757 | $25K |
| Citadel Advisors | 0.00% | Add +41.4% | 14,963 | $15K |
| UBS Group AG | 0.00% | Add +546.9% | 6,469 | $7K |
"% of holder's portfolio" is LSBCF's weight in each manager's 13F, not the share of Lakeshore Biopharma Co. Ltd. the manager owns.